Hurlen M - Search Results

1

Influence of aspirin on inflammatory markers in patients after acute myocardial infarction.

Solheim S, Arnesen H, Eikvar L, Hurlen M, Seljeflot I. Solheim S, et al. Among authors: hurlen m. Am J Cardiol. 2003 Oct 1;92(7):843-5. doi: 10.1016/s0002-9149(03)00897-x. Am J Cardiol. 2003. PMID: 14516890 Clinical Trial.

2

Warfarin, aspirin, or both after myocardial infarction.

Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H. Hurlen M, et al. N Engl J Med. 2002 Sep 26;347(13):969-74. doi: 10.1056/NEJMoa020496. N Engl J Med. 2002. PMID: 12324552 Free article. Clinical Trial.

3

Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease.

Andersen K, Hurlen M, Arnesen H, Seljeflot I. Andersen K, et al. Among authors: hurlen m. Thromb Res. 2002 Oct 1;108(1):37-42. doi: 10.1016/s0049-3848(02)00405-x. Thromb Res. 2002. PMID: 12586130 Clinical Trial.

4

Soluble tissue factor as predictor of future events in patients with acute myocardial infarction.

Seljeflot I, Hurlen M, Hole T, Arnesen H. Seljeflot I, et al. Among authors: hurlen m. Thromb Res. 2003;111(6):369-72. doi: 10.1016/j.thromres.2003.09.019. Thromb Res. 2003. PMID: 14698655 Clinical Trial. No abstract available.

5

Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis.

Hurlen M, Eikvar L, Seljeflot I, Arnesen H. Hurlen M, et al. Thromb Res. 2006;118(4):433-8. doi: 10.1016/j.thromres.2005.07.023. Epub 2005 Aug 31. Thromb Res. 2006. PMID: 16139331 Clinical Trial.

6

Oral anticoagulation after myocardial infarction.

Hurlen M, Arnesen H. Hurlen M, et al. Herz. 2008 Feb;33(1):38-43. doi: 10.1007/s00059-008-3074-8. Herz. 2008. PMID: 18273576 Review.

7

Less benefit from warfarin in diabetics after myocardial infarction?

Smith PJ, Hurlen M, Abdelnoor M, Arnesen H. Smith PJ, et al. Among authors: hurlen m. Cardiology. 2008;111(3):161-6. doi: 10.1159/000121598. Epub 2008 Apr 25. Cardiology. 2008. PMID: 18434719 Clinical Trial.

8

The effect of different antithrombotic regimens on platelet aggregation after myocardial infarction.

Hurlen M, Seljeflot I, Arnesen H. Hurlen M, et al. Scand Cardiovasc J. 1998;32(4):233-7. doi: 10.1080/14017439850140021. Scand Cardiovasc J. 1998. PMID: 9802142 Free article. Clinical Trial.

9

Effects of warfarin, aspirin and the two combined, on mortality and thromboembolic morbidity after myocardial infarction. The WARIS-II (Warfarin-Aspirin Reinfarction Study) design.

Hurlen M, Smith P, Arnesen H. Hurlen M, et al. Scand Cardiovasc J. 2000;34(2):168-71. doi: 10.1080/14017430050142198. Scand Cardiovasc J. 2000. PMID: 10872704 Free article. Clinical Trial.

10

Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin.

Hurlen M, Seljeflot I, Arnesen H. Hurlen M, et al. Thromb Res. 2000 Sep 1;99(5):487-94. doi: 10.1016/s0049-3848(00)00277-2. Thromb Res. 2000. PMID: 10973679 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters